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Abstract
Background: Mitogen-activated protein kinase (MAPK) cascades (p38, JNK, ERK pathways) are involved in cell fate
acquisition during development. These kinase modules are associated with scaffold proteins that control their
activity. In Drosophila, dMP1, that encodes an ERK scaffold protein, regulates ERK signaling during wing
development and contributes to intervein and vein cell differentiation. Functional relationships during wing
development between a chromatin regulator, the Enhancer of Trithorax and Polycomb Corto, ERK and its scaffold
protein dMP1, are examined here.
Results: Genetic interactions show that corto and dMP1 act together to antagonize rolled (which encodes ERK) in
the future intervein cells, thus promoting intervein fate. Although Corto, ERK and dMP1 are present in both
cytoplasmic and nucleus compartments, they interact exclusively in nucleus extracts. Furthermore, Corto, ERK and
dMP1 co-localize on several sites on polytene chromosomes, suggesting that they regulate gene expression
directly on chromatin. Finally, Corto is phosphorylated. Interestingly, its phosphorylation pattern differs between
cytoplasm and nucleus and changes upon ERK activation.
Conclusions: Our data therefore suggest that the Enhancer of Trithorax and Polycomb Corto could participate in
regulating vein and intervein genes during wing tissue development in response to ERK signaling.
Background
The mitogen-activated protein kinase (MAPK) pathways
are evolutionary conserved signaling pathways used by
eukaryotic cells to regulate gene expression during
diverse processes such as proliferation, differentiation,
apoptosis, adaptation to changes in their environment,
and so on (for a review, see [1]). MAPK proteins are
serine-threonine kinases that can phoshorylate targets in
the cytoplasm or the nucleus in response to stimuli
such as mitogenic or stress signals. MAPKs can be
grouped into three classes depending on the stimuli
they respond to. Extracellular regulated kinases (ERK)
are mainly activated by mitogenic stimuli such as
growth factors and hormones, whereas c-Jun N-terminal
kinases (JNK) and p38 kinases respond predominantly
to stress stimuli. Kinases associate with scaffold proteins
that regulate signaling by providing critical spatial and
temporal specificities. Notably, the scaffold protein MP1
forms a signaling complex with MEK and ERK thus
facilitating ERK activation [2,3]. One of the best charac-
terized mechanisms by which MAPKs regulate gene
expression involves phosphorylation of transcription fac-
tors, which consequently modifies their activity, regulat-
ing either their intracellular location, their stability, their
binding to DNA, or their interactions with regulatory
proteins (for a review, see [4]).
Although the traditional view has been that most
phosphorylation events do not occur directly at promo-
ters of genes that are ultimately controlled by MAPK
pathways, recent reports have highlighted some cases
where MAPKs are integral components of transcrip-
tional activation complexes. For example, during mam-
malian myoblast differentiation, p38 is recruited to the
promoters of myogenic genes together with the muscle-
regulatory factors MyoD and MEF2C [5]. In pancreatic
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ERK1/2 MAPKs are bound to the insulin gene promoter
in the same complex as their transcription factor sub-
strates MafA, Beta2 and PDX-1 [6]. In yeast, the p38-
related Hog1 kinase coordinates the transcriptional pro-
gram required for cell survival upon osmostress: active
Hog1 interacts with the transcription factor Hot1, indu-
cing recruitment of Hog1 to osmostress-responsive pro-
moters [7]. Anchoring of Hog1 to chromatin was shown
to be important to stimulate the recruitment and activa-
tion of RNA Pol II [8]. In addition to this role in tran-
scriptional initiation, Hog1 also behaves as a
transcriptional elongation factor [9]. Genome-wide chro-
matin immunoprecipitation coupled with microarrays
(ChIP-Chip) experiments have revealed that two other
yeast MAPKs involved in pheromone response, Fus3
and Kss1, are bound to several genes that are expressed
upon pheromone pathway activation [10].
Once bound to chromatin, MAPKs do not only modu-
late transcription factor activity and RNA Pol II recruit-
ment, but also regulate gene expression by inducing
changes in chromatin organization and epigenetic his-
tone modifications. Indeed, yeast Hog1 facilitates
recruitment of either the histone deacetylase Rpd3-Sin3
complex [11], the SAGA complex which contains both
histone acetylation and de-ubiquitylation activities [12],
or the SWI-SNF chromatin remodeling complex [13].
During mammalian myoblast differentiation, p38 targets
the SWI-SNF complex [5] as well as the ASH2L
Trithorax complex, that contains a histone methyl-
transferase, to muscle-specific genes [14]. It is tempting
to speculate that binding of these complexes to chroma-
tin relies on phosphorylation of some of their compo-
nents by MAPKs. For example in mammals, the
downstream MAPKAP3 kinase, once activated by phos-
phorylation in response to mitogenic or stress signals,
phosphorylates some members of the chromatin Poly-
comb Repressive Complex 1 (PRC1). This results in dis-
sociation of PRC1 from chromatin and subsequent de-
repression of target genes [15]. Altogether, these data
show that chromatin reorganization mediated by nucleo-
some remodeling and epigenetic mark modifications is
an important process to regulate gene expression in
response to MAPK signaling. This process could involve
a dynamic switch between the binding of either a silen-
cing complex or an activating complex on a target gene.
In most of the examples mentioned above, these
repressing and activating complexes are formed by pro-
teins of the Polycomb-group (PcG) and Trithorax-group
(TrxG) which combine into several heteromeric com-
plexes that bind chromatin. PcG and TrxG complexes
regulate gene expression by modulating chromatin
structure, in particular by depositing specific post-trans-
lational histone modifications and by nucleosome
remodeling. PcG complexes lead to compact, transcrip-
tionally inactive chromatin, whereas TrxG complexes
counteract PcG-mediated repression and maintain chro-
matin in an open conformation that facilitates transcrip-
tion (for a review, see [16]). A third class of proteins,
the Enhancers of Trithorax and Polycomb (ETP), is
involved in PcG- as well as TrxG-mediated gene regula-
tion (for a review, see [17]). Interestingly, ETPs allow
the recruitment on chromatin of either PcG or TrxG
complexes and could therefore participate in a switch
between activation and repression. The first ETP
mutants have been identified in Drosophila as enhancers
of both Polycomb-group (PcG) and trithorax-group
(trxG) mutations [18]. Although not found in any of the
PcG or TrxG core complexes purified so far, ETPs
interact with these complexes and are required for both
PcG-mediated silencing and TrxG-mediated activation.
For example, mutants of the ETP gene Asx enhance
homeotic phenotypes of both PcG and trxG mutations
[19]. The GAGA factor encoded by Trithorax-like (Trl)
was first described as an activator of Hox gene expres-
sion and later shown to play a role in recruitment of
PcG complexes [20,21]. The HMGB protein DSP1
b e h a v e sa sa nE T Ps i n c eadsp1 null allele exhibits a
PcG p h e n o t y p eb u te n h a n c e sa tt h es a m et i m et h ep h e -
notype of several trxG mutants [22]. Furthermore, DSP1
is required for PcG complex recruitment to chromatin
[23]. Lastly, corto, which is ubiquitously expressed all
along development, presents the characteristics of an
ETP since loss-of-function mutants exhibit both PcG
and trxG phenotypes and enhance the phenotype of
some PcG as well as trxG mutants [24,25]. The Corto
protein interacts not only with PcG and TrxG proteins,
but also with other ETPs such as GAGA and DSP1,
which suggests that different combinations of ETPs
could favor the recruitment of either PcG or TrxG com-
plexes on chromatin [26,27]. Nevertheless, the mechan-
ism through which ETPs could exert this dual function
remains to be investigated.
corto loss-of-function mutants exhibit several pheno-
types, among them ectopic veins on wings which recall
the phenotype induced by a gain-of-function mutation of
rolled (rl) that encodes the MAPK ERK [25,28]. In Droso-
phila, specification and differentiation of wing tissues (i.e.
vein and intervein) occur in wing imaginal discs during
the third larval and pupal stages and rely on several devel-
opmental signals including those mediated by EGF, BMP,
Hedgehog and Wnt (for a review, see [29]). Signaling
mediated by the Drosophila EGF Receptor (DER) is crucial
for early specification of the longitudinal vein primordia
called proveins, as well as for differentiation of vein and
intervein cells (for a review, see [30]). Once activated by
one of its ligands, DER activates a phosphorylation cascade
leading to ERK signaling. Early ERK signaling in wing discs
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ritories, ERK maintains expression of rhomboïd (rho),
which is required to direct provein cells to differentiate as
vein cells [32]. rho encodes a serine-threonine protease
which is required to process EGFR ligands and thus parti-
cipates in a positive feed-back loop that maintains high
levels of ERK activity [33,34]. On the other hand, ERK sig-
naling represses blistered (bs) expression. bs, that encodes
a homolog of the mammalian Serum Response Factor
(SRF), is expressed in the future intervein cells and con-
trols the specification of intervein tissue [35,36]. Later dur-
ing development, at the pupal stage, ERK signaling is also
required to promote intervein cell differentiation [31]. The
formation of vein and intervein tissues thus depends on
the outcome of a fine-tuned balance between rho and bs
expression patterns, which are both regulated by ERK sig-
naling. Furthermore, the scaffold protein dMP1 also parti-
cipates in ERK signaling during vein and intervein
differentiation [3]. The wing phenotype of corto mutants,
but also the fact that we isolated dMP1 in a two-hybrid
screen using Corto as bait, prompted us to address the
potential role of this ETP in relation to ERK signaling dur-
ing wing vein and intervein differentiation. Our genetic
interactions between corto and genes encoding some
actors of the ERK signaling pathway, i.e. rl itself, dMP1, bs
and rho show that corto and dMP1 contribute to antago-
nize rl vein-promoting function in future intervein cells.
Biochemical analyzes show that Corto interacts directly
with ERK. Furthermore, Corto is phosphorylated and its
phosphorylation increases upon ERK activation. Surpris-
ingly, ERK and dMP1 associate with Corto exclusively in
the nucleus. As suggested by immunolocalizations on
polytene chromosomes, a dMP1/ERK/Corto complex
might be targeted to chromatin to directly regulate
gene expression, thus allowing proper wing tissue
differentiation.
Results and Discussion
corto contributes to intervein tissue differentiation
We first investigated the ectopic vein phenotype of corto
mutants using three different recessive lethal alleles:
corto
420, corto
07128b and corto
L1. corto
420 is a deletion of
the corto locus [25], corto
07128b a P-element insertion
located 0.5 kb upstream of corto 5’-UTR [37], and cor-
to
L1 an EMS-induced mutation [38]. As already
described for corto
420 [24,25], heteroallelic combinations
using corto
07128b, corto
L1 and a deficiency encompassing
corto [Df(3R)6-7] are poorly viable, since we observed
0% to 10% escapers depending on combinations. There-
fore, these three alleles are true loss-of-function alleles.
This was confirmed by quantitative RT-PCR analysis on
wing discs from third instar larvae, that showed absence
of corto transcripts in corto
420/Df(3R)6-7 and corto
07128b/
Df(3R)6-7 larvae (Figure 1). In contrast, corto
L1/Df(3R)6-
7 larvae exhibited the same level of corto transcripts as
wild-type flies, which suggests that the mutation in cor-
to
L1 rather affects the level or activity of Corto protein.
As already described [25], corto
420/+ heterozygous
flies exhibited very few ectopic veins (2.2% to 8.6%).
This phenotype was more penetrant in corto
L1/+ (49%
to 52.2%) and corto
07128b/+ (97.4% to 97.8%) heterozy-
gous flies (Table 1 and Figure 2A). Since both corto
420
and corto
07128b are devoid of corto transcripts, the dis-
crepancy between these alleles may be a consequence
of an interaction with the genetic background. For all
combinations, the few heteroallelic corto escapers dis-
played a stronger ectopic vein phenotype than corto
heterozygous flies (Figure 2B-D). Ectopic veins mainly
arose close to longitudinal veins 2, 3, 5 and to the pos-
terior cross-vein, which seems to be the case for most
mutations that induce ectopic vein phenotypes [32].
Interestingly, over-expressing corto using a UAS::corto
construct and the wing specific Beadex::Gal4 (Bx::Gal4,
d a t an o ts h o w n )o rscalloped::Gal4 (sd::Gal4)d r i v e r
also induced extra pieces of vein tissue in all flies (Fig-
ure 2E). Since both corto over-expression and loss-of-
function induced the same phenotype, one possibility
is that Corto may be required in stoechiometric
amount to allow correct wing tissue differentiation.
This feature characterizes proteins that act through
formation of complexes. Indeed, complexes are very
sensitive to the relative amounts of their components,
and can be disrupted either by an excess or a shortage
of one of these [39].
Figure 1 Quantification of corto transcripts by quantitative RT-
PCR on wing discs from corto
420/Df(3R)6-7, corto
L1/Df(3R)6-7
and corto
07128b/Df(3R)6-7 third instar larvae. The relative corto
expression level was obtained by normalization on rp49 (black bars)
or spt6 (grey bars) level. For each mutant genotype, this normalized
level was compared to that of wild type (w
1118) wing discs.
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function in wing tissue differentiation, we crossed the
UAS::corto line with the hs::Gal4 driver strain allowing
staged Gal4 expression (Table 2). The highest percen-
tage of ectopic vein phenotype was obtained when heat-
shock was applied between 96 to 120 hours after egg
laying, which corresponds to the mid to late third instar
larval stage. Interestingly, it has been shown that, from
late third instar larval stage to pupal stage, down-regula-
tion of ERK signaling is crucial for wing tissue forma-
tion: indeed, expression of a constitutively active form
of the MAPKK Raf at the third instar larval stage
induces vein loss, whereas expression of a dominant
negative form of the receptor DER at pupal stage leads
to formation of ectopic veins [31].
In conclusion, corto misregulation (either loss-of-
function or over-expression) induced ectopic veins that
formed within intervein tissue and never truncated
veins. This observation suggested that Corto contri-
butes to intervein tissue differentiation, whereas it does
not seem to be involved in vein formation. We have
previously shown that corto interacts with some TrxG
genes during wing tissue formation. Indeed, moira, kis-
met and ash1 mutants enhance the ectopic vein phe-
notype of corto
420 [25]. Furthermore, several corto
alleles enhance the ectopic vein phenotype of muta-
tions in snr1 that encodes a component of the SWI/
SNF complex [38,40], a chromatin-remodeling complex
also involved in wing tissue differentiation [41-43].
O n eh y p o t h e s i si st h a tC o r t o ,a sa nE T P ,c o u l d
participate in the recruitment of TrxG complexes to
regulate expression of genes involved in wing tissue
differentiation.
To clarify the role of corto in the formation of inter-
vein tissue, we performed genetic interaction assays
between corto and the intervein-promoting gene blis-
tered (bs), or the vein-promoting gene rhomboïd (rho).
As expected for a bs loss-of-function allele [35,36],
wings of flies heterozygous for bs
EY23316 exhibited a
moderate ectopic vein phenotype, but none showed blis-
ters in the wings (Table 1 and Figure 2F). corto
07128b
enhanced the ectopic vein phenotype induced by
bs
EY23316 (compare Figure 2G to Figure 2F). In addition,
32.5% of these trans-heterozygous flies had blisters in
the wings (Table 1 and Figure 2H). These blisters,
which result from impaired adhesion between the ven-
tral and dorsal wing surfaces, could be caused by forma-
tion of many vein cells within intervein tissue. They are
frequently observed in bs mutants [35] or when rho is
over-expressed [36]. This result therefore showed that
bs and corto act synergistically to promote intervein cell
fate. Ectopic over-expression of rho using the rho
EP3704
allele and the sd::Gal4 driver induced ectopic veins for
most of the flies and in a few cases (9.5%) formation of
blisters (Figure 2I and Table 1). This phenotype was
similar to that induced by over-expressing rho under
control of a heat-inducible promoter [32]. Both corto
420
and corto
07128b alleles enhanced this phenotype since the
number of flies with blisters in the wings significantly
increased (Table 1 and Figure 2J). This observation
showed that corto antagonizes rho in vein formation.
Taken together, these results suggest that corto might
antagonize rl vein-promoting function in future inter-
vein cells. corto misregulation could therefore lead to
deregulation of certain vein and intervein-promoting
genes. Indeed, we observed deregulation of bs and rho
Table 1 corto mutants induce ectopic vein phenotypes and interact with blistered (bs) and rhomboïd (rho) during wing
tissue differentiation
Genotype Total females observed % females with ectopic veins only % females with blistered wings
corto
420/+ 70 8.6 0
+/corto
420 45 2.2 0
corto
L1/+ 51 49 0
+/corto
L1 90 52.2 0
corto
07128b/+ 78 97.4 0
+/corto
07128 46 97.8 0
+/bs
EY23316 136 100 0
+/bs
EY23316 ; corto
07128b/+ 80 67.5 32.5
a
+/rho
EP3704 68 0 0
sd::Gal4/+; +/rho
EP3704 105 90.5 9.5
sd::Gal4/+; corto
420 /rho
EP3704 34 58.8 41.2
a
sd::Gal4/+; corto
07128b /rho
EP3704 90 51.1 48.9
a
For all genotypes, the first allele was brought by the mother. Only female phenotypes are reported here, but similar results were obtained for males. Numbers of
females with blistered wings in flies containing a corto mutation and the bs
EY23316 or rho
EP3704 allele were compared to those of flies containing the bs
EY23316 or
rho
EP3704 allele only (Z-test,
a p < 0.001).
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L1/Df
(3R)6-7 escapers: in these cells, bs is down-regulated
(Figure 2K) whereas rho is ectopically expressed (Figure
2L).These cells could thus acquire a vein fate.
Corto and dMP1 act together and participate in the
control of wing tissue differentiation
S i n c et h ew i n gp h e n o t y p eo fcorto mutants resembles
the one induced by hyperactivation of ERK signaling
pathway, we wondered whether corto was involved in
the regulation of this pathway during wing development.
We first tested genetic interactions between corto and
rolled using the UAS::rolled strain which allows targeted
ERK over-expression when crossed with a Gal4 driver.
All flies over-expressing rolled with the sd::Gal4 driver
at 25°C exhibited a mild ectopic vein phenotype ([3] and
Figure 3A). Expressivity of this phenotype was enhanced
by the corto
07128b allele (Figure 3B). This result suggests
that the roles of corto and rolled in vein-promoting
function are antagonistic.
We also used the UAS::rolled
Sem (rl
Sem) transgene that
encodes a hyper-active form of ERK [28,44]. At 18°C,
Figure 2 corto regulates wing tissue differentiation in interaction with blistered (bs) and rhomboïd (rho). (A): Wings from corto
07128b/+
flies exhibit ectopic veins (shown by asterisks) within intervein tissue (L1-L5: longitudinal veins; ACV and PCV: anterior and posterior cross-veins).
(B, C, D): This phenotype is more severe in flies heteroallelic for corto loss-of-function mutations (corto
07128b/corto
L1; corto
07128b/corto
420; corto
L1/Df
(3R)6-7 ). (E): corto over-expression induces ectopic veins (shown by asterisks). (F to J): corto
07128b enhances the ectopic vein phenotype (shown
by asterisks) and the blistered phenotype (shown by arrows) induced by the bs
EY23316 loss-of-function allele (F, G, H) and by rho over-expression
using the rho
EP3704 allele (I, J). (K, L): in situ hybridization of 30 h pupal wings from corto
L1/Df(3R)6-7 mutants with bs probe (K) or rho probe (L);
white asterisks point to bs and rho deregulation.
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Sem transgene under
control of the sd::Gal4 driver exhibited ectopic veins.
This phenotype was much stronger than the one
induced by rolled over-expression (compare Figure 3 to
3). For 88% of these flies, this phenotype was very
strong since one or the two wings showed blisters
(Table 3 and Figure 3C). Surprisingly, penetrance and
expressivity of the rl
Sem over-expression phenotype were
lowered by corto
420 and corto
07128b alleles, as only 49.4%
of corto
420 flies and 55.1% of corto
07128b ones exhibited
blisters in one or both wings (Table 3) and blisters were
smaller (Figure 3D). This result confirmed that corto
and rl interact during wing tissue formation. However,
the observation that corto mutation enhanced a mild-
activation of ERK pathway (as induced by UAS::rl)
whereas slowing-down a hyper-activation (as induced by
UAS::rl
Sem) is paradoxical and requires further experi-
ments to be fully understood.
We have recently shown that the Drosophila ortholog
of MP1, dMP1, antagonizes rl vein-promoting function
in the future intervein cells of the wing [3]. Further-
more, we isolated dMP1 in a two-hybrid screen using
Corto as bait (see below and Figure 4B). We thus tested
the genetic interactions between corto and dMP1.A s
already described [3], down-regulation of dMP1 by RNA
interference using the sd::Gal4 driver induced ectopic
veins in 78.5% of flies (Table 3 and Figure 3E). This per-
centage increased to 92.2% and 100% in combination
with corto
420 or corto
07128b, respectively (Table 3). With
corto
07128b, the expressivity of the ectopic vein pheno-
type was also enhanced (compare Figure 3F to Figure2A
a n d3 E ) .T h e r e f o r e ,t h e s er e s u l t ss h o w e dt h a tcorto and
dMP1 act synergistically and participate in intervein tis-
sue differentiation in response to ERK signaling.
Corto interacts in vitro directly with ERK and indirectly
with dMP1
We have previously shown that dMP1 forms a complex
with ERK, which is required for the proper development
of intervein cells [3]. To understand the molecular bases
of the relationship between Corto, dMP1 and ERK, we
first questioned the physical interaction between Corto
and ERK. We carried out GST pull-down assays using
in vitro translated ERK and GST-Corto fusion proteins.
Structural analysis of Corto has shown that this 550
amino-acid protein contains three globular domains that
might correspond to functional domains ([26] and
Figure 4A). The first one is located at position 127-
203 and exhibits strong structural similarities with
Table 2 Staged corto over-expression induced ectopic vein phenotypes mostly during late larval development
Genotype +/hs::Gal4 UAS::corto/hs::Gal4
Time of heat-shock (hours After Egg
Laying AEL)
Total females
observed
% females with ectopic
veins
Total females
observed
% females with ectopic
veins
No heat-shock 32 0 195 17.9
48 h-72 h AEL
(L2 larvae)
127 3.1 182 25.8
72 h-96 h AEL
(early to mid L3 larvae)
123 3.2 235 29.8
96 h-120 h AEL
(mid to late L3 larvae)
56 3 216 46.3
a
120 h-136 h AEL
(young pupae)
78 5.1 309 31.7
For all genotypes, the first allele was brought by the mother. Only female phenotypes are reported here, but similar results were obtained for males. The number
of females with ectopic veins when heat-shock was applied between 96 h-120 h AEL was compared to the ones of females with ectopic veins obtained after
heat-shock applied between 72 h-96 h AEL or 120 h-136 h AEL (Z-test,
a p < 0.001).
Figure 3 corto interacts with rl and dMP1 during wing
development. (A, B): corto loss-of-function (corto
07128b) enhances
the ectopic vein phenotype (shown by asterisks) induced by rl over-
expression. (C, D): corto loss-of-function (corto
07128b) diminishes the
blistered phenotype (shown by arrows) induced by rl
Sem over-
expression. (E, F): corto loss-of-function (corto
07128b) enhances the
ectopic vein phenotype (shown by asterisks) induced by dMP1
down-regulation.
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found in some regulators of chromatin structure (for a
review, see [45]). The two others, located at positions
418-455 and 480-550, present no obvious similarities
with known protein domains. In vitro translated ERK
protein was retained on GST-C1/324 and GST-C325/
550 beads containing the NH2-terminal half and the
COOH-terminal half of Corto, respectively (Figure 4A).
In contrast, ERK was not retained on GST-C127/207
beads containing the Corto chromodomain, or on GST-
C418/503 beads containing part of the two COOH-
terminal globular domains. The lack of interaction with
GST-C127/207 and GST-C418/503 suggested that none
of these domains was sufficient to mediate Corto-ERK
interaction, either because of inappropriate folding of
these short domains in the GST fusion proteins, or
because none of these two fragments contains the
sequences that mediate ERK binding. Taken together,
these results showed that Corto interacts directly with
ERK in vitro. Further experiments are needed to deter-
mine the precise domains or residues that mediate the
interaction between Corto and ERK.
Since we isolated dMP1 in a two-hybrid screen using
the NH2-terminal part of Corto as a bait (Figure 4B), we
next questioned the physical interaction between Corto
and dMP1. We performed GST pull-down assays using
GST-dMP1 fusion protein and in vitro translated Corto
to see whether their interaction was direct or indirect.
Indeed, indirect interactions via yeast proteins have
already been observed in two-hybrid experiments [46].
As shown in the middle panel of Figure 4C, the same
result was obtained using GST or GST-dMP1 beads
indicating that there was no specific direct interaction
between Corto and dMP1. However, by incubating
GST-dMP1 beads with total embryonic protein extract,
we observed after blotting with anti-Corto antibodies
that Corto was specifically retained on GST-dMP1
beads (bottom panel of Figure 4C). Therefore, we con-
cluded that Corto and dMP1 interact via additional fac-
tors. One potential candidate could be ERK, since it
directly interacts with Corto (as shown above) and with
dMP1 [3].
Table 3 corto interacts with rolled (rl) and dMP1 during wing tissue differentiation
Genotype Total females
observed
% females with ectopic
veins only
% females with one
blistered wing
% females with two
blistered wings
sd::Gal4/+;+/UAS::rl
Sem 108 12 40.7 47.3
sd::Gal4/+;corto
420/UAS::rl
Sem 85 50.6
a 36.5 12.9
a
sd::Gal4/+;corto
07128b/UAS::
rl
Sem
78 44.9
a 44.9 10.2
a
+/sd::Gal4; UAS::dsMP1/+ 158 78.5 0 0
+/sd::Gal4; UAS::dsMP1/+;
+/corto
420
90 92.2
b 00
+/sd::Gal4; UAS::dsMP1/+;
+/corto
07128b
92 100 0 0
For all genotypes, the first allele was brought by the mother. Only female phenotypes are reported here, but similar results were obtained for males. Numbers of
females with ectopic veins only or with two blistered wings among flies bearing a corto allele and over-expressing rl
Sem were compared to the one of flies over-
expressing rl
Sem only. Numbers of females with ectopic veins among flies containing the UAS::dsMP1 transgene, the sd::Gal4 transgene and a corto mutation were
compared to that of flies containing the UAS::dsMP1 and the sd::Gal4 transgenes only (Z-test,
a p < 0.001;
b p < 0.05).
Figure 4 Corto interacts in vitro directly with ERK and indirectly
with dMP1. (A): GST pull-down assays show direct interaction
between Corto and ERK. Top: Schematic representation of Corto full-
length and truncated forms (black box: chromodomain; grey boxes:
COOH-terminal globular domains). Bottom: Coomassie staining of
fusion proteins (shown by arrows) and autoradiography of the GST
pull-down assays with in vitro translated
35S-ERK. (B): Leucine test of
two-hybrid experiment shows that the NH2-terminal half of Corto
(LexA-C1/324 corresponding to amino-acids 1-324) interacts with full
length dMP1 (B42AD-dMP1). Negative controls: LexA and B42AD-
dMP1; LexA-C1/324 and B42AD; positive controls: LexA53 and B42ADT.
(C): GST pull-down assays using a GST-dMP1 fusion protein show that
the Corto-dMP1 interaction is not direct. Top: Coomassie staining of
fusion proteins (shown by arrows). Middle: autoradiography of the GST
pull-down assays showing no specific interaction between GST-dMP1
beads and in vitro translated
35S-Corto. Bottom: peptide pull-down
assay using total embryonic protein extract and GST-dMP1 shows that
Corto (revealed by anti-Corto antibodies) is specifically retained on
GST-dMP1 beads (shown by an arrow).
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Page 7 of 14Corto is located both in the cytoplasm and the nucleus
and is phosphorylated
Upon activation of the MAPK cascade, ERK is phos-
phorylated in the cytoplasm. Di-phosphorylated ERK
(dP-ERK) phosphorylates in turn a large number of tar-
gets with diverse functions and different subcellular
localizations. In particular, part of dP-ERK is translo-
cated into the nucleus where it phosphorylates some
transcription factors (for reviews, see [1,4]). Mammalian
MP1 is present in the cytoplasm in association with
ERK but its possible nuclear localization has not been
reported [47,48]. Nevertheless, we have recently shown
that dMP1 is present both in the cytoplasm and the
nucleus [3]. We thus asked whether Corto was present
in the same compartments as ERK and dMP1. Corto
was detected in nuclear and cytoplasmic extracts from
embryos (Figure 5A), third instar larvae (data not
shown) and Schneider S2 cells (Figure 5B). A similar
nuclear and cytoplasmic distribution was observed for a
Corto-FLAG fusion protein expressed in S2 cells (Figure
5C). Both Corto and Corto-FLAG exhibited several
isoforms very close to each other in size, with the lowest
isoforms being more abundant in the cytoplasm than in
the nucleus (Figure 5A-C). Corto is very rich in serine
(16%), threonine (4.5%), tyrosine (2.9%), and presents
many predicted phosphorylation sites for several kinases
distributed all along the sequence (according to NetPhos
predictions: 28 phosphorylable serines, 6 threonines, and
3 tyrosines). Hence we checked whether the isoforms
we observed could indeed correspond to differentially
phosphorylated molecules. As shown in Figure 5D, the
upper bands of Corto-FLAG disappeared after lambda
phosphatase treatment. Altogether, these results showed
that Corto is a phosphorylated protein present both in
the cytoplasm and in the nucleus. In addition, the Corto
phosphorylation pattern seemed to be different between
the two cellular compartments, with enrichment in
highly phosphorylated forms in the nucleus. Phosphory-
lation of M33, a chromatin regulator, has been shown to
regulate its nuclear translocation [49]. Further experi-
ments are required to determine if Corto localization is
regulated through a similar mechanism.
The phosphorylation pattern of Corto is controlled at
least partially by ERK pathway
Since Corto is phosphorylated and interacts in vitro with
ERK, it is tempting to speculate that Corto could be
phosphorylated in response to activation of the corre-
sponding MAP kinase cascade. To answer this question,
we transfected S2 cells in absence of serum with a plas-
mid allowing Corto-FLAG expression. After two days,
w et r a n s i e n t l ya c t i v a t e dt h eM A Pk i n a s ec a s c a d eb ya
short (15 minutes) treatment either with serum, with
serum plus insulin or with serum plus PMA. In all three
conditions, faint upper Corto isoforms appeared (brace
on Figure 6A, upper panel), showing that Corto phos-
phorylation was induced very rapidly upon ERK activa-
tion. To confirm the existence of these faint upper
isoforms, we immunoprecipitated Corto from these
extracts using anti-FLAG antibodies and blotted the
immunoprecipitates with antibodies directed against
phosphoproteins (Figure 6A,l o w e rp a n e l ) .T h i se x p e r i -
ment revealed first that Corto is constitutively phos-
phorylated even without MAP kinase activation. Second,
ERK activation induced an hyperphosphorylation of
Corto since an upper smear containing several bands
very close in size appeared in all three conditions of
activation tested.
As another way to activate the ERK pathway, we co-
expressed Corto-FLAG and tagged forms of either ERK,
ERK
Sem or Ras
V12 in S2 cells. Similar to ERK and ERK-
Sem over-expression, over-expression in flies of a consti-
tutively active form of Ras, Ras
V12, induces ectopic vein
cells [50]. Surprisingly, smaller Corto isoforms appeared
when constitutively activating the ERK pathway with
Figure 5 Corto is a phosphorylated protein located both in the
cytoplasm and in the nucleus. (A to C): Corto is present in the
cytoplasm and in the nucleus and exhibits several isoforms very
close in size (indicated by a brace). In the nucleus, the higher
isoforms are predominant. (A, B): Western-blot using anti-Corto
antibodies and cytoplasmic or nuclear extracts from wild-type
embryos (A) or S2 cells (B). (C): Western-blot with anti-FLAG
antibodies using cytoplasmic and nuclear extracts from S2 cells
expressing or not a Corto-FLAG fusion protein. Cyt: 50 μg
cytoplasmic extract; Nuc: 10 μg nuclear extract. In A, B, C, b-tubulin
and lamin were used as cytoplasmic and nuclear loading controls,
respectively. (D): The different Corto isoforms correspond to proteins
that are differently phosphorylated: Western-blot with anti-FLAG
antibodies after phosphatase treatment of 15 μg total extract from
S2 cells expressing a Corto-FLAG fusion protein shows that the
upper band disappears. In this experiment, only the two major
Corto-FLAG isoforms are visible because of the low amount of total
extract loaded.
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Page 8 of 14either ERK, ERK
Sem or Ras
V12 (Figure 6B). One possibi-
lity is that these smaller isoforms could correspond to
partially dephosphorylated Corto molecules. Taken
together, these experiments demonstrate that Corto pre-
sents a complex phosphorylation pattern that depends
at least on ERK signaling. It is tempting to speculate
that some phosphorylations are performed directly by
ERK. Indeed, Corto contains 3 SP sites at positions 139,
190 and 428 that correlate with theoretical ERK1/ERK2
phosphorylation sites [51]. Identification of Corto phos-
phorylation sites as well as phospho-mutant analysis and
determination of Corto phosphorylation status when
bound to chromatin would help to better understand
the role of these phosphorylation events.
Interaction between ERK and dMP1 or Corto takes place
in the nucleus only
We next performed co-immunoprecipitation experi-
ments to see whether Corto interacts with ERK and
dMP1 in vivo. We have previously shown that ERK and
dMP1 co-immunoprecipitate in a total protein extract
[3]. In order to determine the subcellular localization of
this dMP1/ERK complex, we carried out co-immunopre-
cipitation experiments using cytoplasmic or nuclear
extracts of S2 cells expressing dMP1 and ERK tagged
proteins. Surprisingly, dMP1-Myc co-immunoprecipi-
tated with ERK-FLAG in the nuclear extract only
(Figure 7A). Corto-Myc and ERK-FLAG also co-immu-
noprecipitated in the nuclear extract only (Figure 7B).
In this last experiment, all Corto isoforms were co-
immunoprecipitated with ERK. In both cases, the lack of
co-immunoprecipitation in cytoplasmic extracts was
confirmed by using two different protocols to prepare
nuclear and cytoplasmic extracts (see the Methods sec-
tion). The co-immunoprecipitation observed between
Corto and ERK fusion proteins was confirmed with
endogenous proteins from a total embryonic extract
using anti-dP-ERK antibody (Figure 7C). Furthermore,
this experiment showed that Corto was able to interact
with dP-ERK. Lastly, we observed no co-immunoprecipi-
tation between Corto-FLAG and dMP1-Myc whether in
total, cytoplasmic or nuclear extracts (data not shown).
Labile protein interactions can be stabilized by cross-
linking before performing cell extracts, although such
treatment does not allow separating cytoplasmic and
nuclear extracts. When using a total extract from cross-
linked cells, we could detect co-immunoprecipitation
between Corto-FLAG and dMP1-Myc (Figure 7D). This
observation was consistent with our GST pull-down and
peptide pull-down assays showing that the interaction
between dMP1 and Corto was not direct but was prob-
ably mediated by other proteins. Altogether, our co-
immunoprecipitation results suggest that a complex
containing Corto, ERK and dMP1 might exist in the
nucleus only. The core protein of this complex should
be ERK, since it interacts directly with both Corto and
dMP1.
ERK and dMP1 bind polytene chromosomes where they
partially co-localize with Corto
To further analyze the relationship between Corto,
dMP1 and ERK, and since Corto has been shown to
bind polytene chromosomes [26], we analyzed the bind-
ing of ERK and dMP1 onto polytene chromosomes. We
observed that ERK and dMP1 bound polytene chromo-
somes on many sites where they completely co-localized
(Figure 8A). Furthermore, Corto and dMP1 co-localized
on several sites (Figure 8B-C). These results suggest that
a dMP1/ERK/Corto complex might regulate targets
directly on chromatin. Since the co-localization of Corto
with dMP1 is not complete, Corto appears to be an
optional partner of dMP1/ERK on chromatin. Corto
association may require additional factors or may be
controlled by signaling events.
Previously, other scaffold proteins have been reported
to bind chromatin. This is thec a s eo ft h es c a f f o l dp r o -
tein Ste5p in the pheromone pathway of yeast which
interacts with the MAPKs Fus3p and Kss1p and occu-
pies the same mating-type genes. Ste5p has then been
suggested to function as an adaptor for protein-protein
interactions both at the plasma membrane and in the
Figure 6 The phosphorylation pattern of Corto depends on the
level of ERK pathway activity. (A): S2 cells in 0% fetal calf serum
were transfected with a plasmid allowing Corto-FLAG over-
expression. 48 hours after transfection, they were submitted to short
ERK pathway activation by a 15 minutes treatment with either 10%
fetal calf serum (lane 2), 10% fetal calf serum plus insulin 10 μg/ml
(lane 3) or 10% fetal calf serum plus PMA 100 ng/ml (lane 4). Total
protein extracts were either directly analyzed by Western blot with
anti-FLAG antibodies (upper panel), or submitted to
immunoprecipitation using anti-FLAG antibodies followed by
immunoblotting with anti-phosphoprotein antibodies (lower panel).
The braces point to the upper Corto isoforms that appear in
response to ERK activation. The asterisk on the lower panel shows
the heavy IgG chains, which have already been shown to be
phosphorylated [62]. (B): Serum-starved S2 cells were either
transfected with a plasmid allowing Corto-FLAG expression (lane 1),
or co-transfected with Corto-FLAG and ERK-FLAG (lane 2), Corto-
FLAG and ERK
Sem-FLAG (lane 3) or Corto-FLAG and Ras
V12 (lane 4),
in order to constitutively activate the ERK pathway. After 48 hours,
total protein extracts were analyzed by Western blot using anti-
FLAG antibodies.
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arrestin, localized both in the cytoplasm and in the
nucleus, is also recruited to target promoters under
opioid receptor stimulation thus enhancing gene tran-
scription [52]. The scaffold protein dMP1 could serve as
an adaptor to connect ERK with other partners directly
on chromatin. It could also allow ERK to form dimers,
as mammalian scaffold proteins have been shown to be
essential to connect ERK dimers to cytoplasmic targets
[53]. It would therefore be interesting to know if ERK is
monomeric or dimeric when bound to chromatin.
Conclusions
We show here that the ETP corto, rl and dMP1 interact
during wing tissue differentiation in Drosophila.C o r t o ,
ERK and dMP1 form a complex exclusively in the
Figure 7 Corto interacts in vivo with ERK in the nucleus only. (A, B): ERK-FLAG co-immunoprecipitates with dMP1-Myc (A) and Corto-Myc (B)
only in nuclear extracts. Immunoprecipitation was performed with either anti-FLAG (FLAG-IP) or anti-HA (Mock-IP) antibodies. Cytoplasmic (Cyt)
and nuclear (Nuc) extracts from S2 cells expressing tagged proteins were analyzed by Western blot using b-tubulin and lamin as cytoplasmic
and nuclear loading controls, respectively. Note that ERK-FLAG (about 50 kDa) co-migrates with the heavy IgG chains (asterisks). (C): Corto co-
immunoprecipitates with the di-phosphorylated form of ERK (dP-ERK) in a total embryonic extract. Immunoprecipitated proteins were revealed
using rat anti-Corto antibodies. (D): dMP1-Myc co-immunoprecipitates with Corto-FLAG only after cross-linking of cells before protein extraction.
Immunoprecipitation was performed using either anti-Myc (Myc-IP) or anti-HA (Mock-IP) antibodies. In A, B, D, immunoprecipitated proteins were
revealed by Western-blot using anti-FLAG or anti-Myc antibodies. Arrows and braces show immunoprecipitated tagged proteins and asterisks
point to heavy or light IgG chains. In A and D, the light IgG chains in the mock-IP lanes are poorly recognized by the secondary antibodies, but
are clearly visible when membranes were stained with Ponceau red (data not shown). S: supernatant after immunoprecipitation; IP: protein G-
agarose beads. 5% of the input and 50% of the immunoprecipitate were loaded onto the gel.
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mosomes where they partially co-localize, suggesting
that the Corto-ERK-dMP1 complex might regulate vein
and/or intervein gene expression directly on chromatin.
Future experiments will be needed to test whether this
complex, via the ETP Corto, participates in the recruit-
ment of TrxG complexes on target genes in response to
ERK signaling.
Methods
Drosophila strains and genetic crosses
Flies were raised on standard yeast-cornmeal medium at
25°C. w
1118 w a su s e da sc o n t r o ls t r a i n .T h ecorto
L1
(EMS-induced allele), corto
07128b, bs
EY23316, rho
EP3704 (P-
insertion alleles) lines were from the Bloomington Stock
Center. The corto
420 line results from imprecise P-ele-
ment excision [24,25]. The transgenic lines UAS::corto
Figure 8 ERK and dMP1 bind polytene chromosomes where they partially co-localize with Corto. (A): Immunostaining of polytene
chromosomes using rabbit anti-ERK (C-16) (left), and guinea-pig anti-dMP1 (center). DNA was stained with DAPI. ERK and dMP1 co-localize on all
sites (right). The staining observed with dMP1 antibodies on centromeric heterochromatin and chromosome four (asterisk) is non-specific, since
the same staining was observed with the pre-immune serum (data not shown). (B): Immunostaining of polytene chromosomes with rabbit anti-
Corto antibodies (left) and guinea-pig anti-dMP1 antibodies (center). Corto and dMP1 co-localize on a number of sites (right, arrows). (C):
Magnification of chromosome 3L extremity showing that Corto and dMP1 co-localize on several sites (yellow arrows).
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Page 11 of 14[24] (transgene on the third chromosome), UAS::rolled
(transgene on the X chromosome) and UAS::rl
Sem [54]
(transgene on the third chromosome) were gifts from
D r .R .R o s s e t( UAS::corto)a n dD r .K .M o s e s( UAS::rl
and UAS::rl
Sem). The UAS::dsMP1 line allowing dMP1
down-regulation by RNA interference (transgene on the
second chromosome) was described previously [3]. Lines
containing a transgene with UAS sequences were
crossed with the hs::Gal4, scalloped::Gal4 (sd::Gal4, [55])
and Beadex::Gal4 (Bx::Gal4, [56]) drivers. All crosses
were performed at 25°C, except those of UAS::rl
Sem with
sd::Gal4 that were performed at 18°C to decrease Gal4
activity and therefore lower transgene expression. To
perform staged corto expression with the hs::Gal4 driver,
Gal4 was induced by 20 minute heat-shocks applied at
various moments during larval and pupal development.
In situ hybridization experiments on pupal wings
White pupae were collected and maintained for 30 h at
25°C. After puparium dissection, pupae were fixed in 8%
formaldehyde for 12 h at 4°C. In situ hybridization with
blistered (EST SD23611) and rhomboïd (EST RE59529)
DIG-UTP labeled RNA probes was performed according
to standard protocols [57].
Q-RT PCR experiments
Total RNA were extracted from 20 third instar larval
discs of each genotype using the PureLink RNA Micro-
kit (Invitrogen) according to the manufacturer’s instruc-
tions. 1 μg of RNA was reverse-transcribed with the
SuperScript
® VILO™ cDNA Synthesis Kit (Invitrogen).
Q-RT PCR experiments were carried out on a Light
Cycler 480 (Roche Diagnostics) with the Maxima Sybr-
Green mix (Fermentas). The primers used were: cortoF
(5’-TGGCCACAGTTCCTAGCATT-3’)a n dcortoR (5’-
GCATGGGATTGGTGTCAGG-3’); rp49F (5’-CCGCT
TCAAGGGACAGTATC-3’)a n drp49R (5’-GACAA
TCTCCTTGCGCTTC-3’); spt6F (5-’CGGAGGAGC
TCTTCGATATG-3’)a n dspt6R (5’-GACAGCTCTGG
GAAGTCGTC-3’). A standard curve of amplification
efficiency for each set of primers was generated with a
serial dilution of cDNA. rp49 or spt6 levels were used
for normalization according to the standard curve
method. Three independent experiments were
performed.
Plasmids and S2 cell transfection
The corto, dMP1, rl and rl
Sem cDNAs were cloned into
Gateway
® Drosophila vectors allowing expression of the
fusion proteins under control of the actin5C promoter,
as previously described [3]. The rl
Sem sequence was
obtained by in vitro mutagenesis using the Quick-
Change
® Site Directed Mutagenesis kit (Stratagene)
according to the manufacturer’s instructions. This gain-
of-function mutation is a G to A transition resulting in
a D to N substitution at position 334 [28]. pMT-Ras
V12
(a gift from Dr. A. Nagel) allowed transient expression
of the constitutively active form of Ras, Ras
V12,u n d e r
the control of the heavy metal inducible promoter
metallothionein [58]. Ras
V12 was induced by treating
transfected cells for 24 h with CuSO4 0.5 mM. For
transfection, S2 cells were cultivated at 25°C in Schnei-
der medium with or without 10% fetal calf serum as
indicated. 5.10
6 cells were transfected with 2 μg of DNA
using Effecten
® transfection reagent (Qiagen) according
to the manufacturer’s instructions (1/10 DNA-Effecten
®
ratio). Cells were collected 48 h (ERK pathway activa-
tion) or 72 h (immunoprecipitation) after transfection.
Protein extracts and phosphatase treatment
Embryos and S2 cell total extracts were prepared by soni-
cation in RIPA buffer [50 mM Tris-HCl pH7.5, 150 mM
NaCl, 25 mM NaVO4,2 5m MN a F ,0 . 1 %S D S ,0 . 5 %N P 4 0 ,
complete protease inhibitors (Roche)]. Cytoplasmic
extracts were prepared either with NE-PER Nuclear and
Cytoplasmic Extraction Reagents (Pierce) according to the
manufacturer’s instructions or by homogenization using a
Dounce potter in low salt buffer as described in [59].
When analyzed by immunoprecipitation, these two kinds
of cytoplasmic extracts gave the same results. Nuclear
extracts were obtained by sonication of the nuclear pellet
in RIPA buffer. Phosphatase treatments of S2 cell extracts
prepared without NaVO4 and NaF phosphatase inhibitors
were performed using Lambda Protein Phosphatase
(Upstate) for a 10 minute incubation time at 37°C.
Western blot analysis and antibodies
Cell lysates or immunoprecipitated proteins were resolved
on 8% SDS-PAGE Anderson gels [60] when separating dif-
ferent isoforms of Corto, or on 12% or 15% classical SDS-
PAGE depending on the molecular weight of proteins.
Western blot experiments were performed according to
standard protocols. Antibodies used were monoclonal
anti-FLAG (F3165, Sigma) or anti-Myc (sc-40, Santa Cruz
Biotechnology) antibodies for fusion proteins, anti-b-
tubulin (E7) and anti-lamin (ADL67.10) antibodies (Devel-
opmental Studies Hybridoma Bank) for control of cyto-
plasmic and nuclear fractions, rat anti-Corto antibodies
[26], monoclonal phosphoserine/threonine/tyrosine anti-
body (MA1-38450, Pierce), rabbit anti-ERK antibodies (C-
16, Santa-Cruz Biotechnology) or monoclonal anti-dP-
ERK E10 antibody (9106, Cell Signaling). Anti-HA anti-
body (H3663, Sigma) was used as a negative control in
immunoprecipitation experiments.
Protein-protein interactions
In vitro transcription-translation and GST pull-down
assays were performed as previously described [26]
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fusion protein [3].
For co-immunoprecipitation experiments, 500 μgo f
protein extracts (total, cytoplasmic or nuclear) were
immunoprecipitated either with monoclonal anti-FLAG
antibody, anti-Myc 9E10 antibody or anti-HA antibody
using magnetic protein G-agarose beads (Ademtech). To
co-immunoprecipitate Corto and dMP1, proteins were
cross-linked before extraction by treating cells with 1%
formaldehyde for 10 minutes followed by neutralization
with 0.13 M glycine. To co-immunoprecipitate Corto
and dP-ERK in embryonic extracts, monoclonal anti-dP-
ERK E10 antibody was covalently bound onto protein
G-agarose beads using standard protocols.
Two-hybrid experiments were performed as previously
described [26], using leucine and X-Gal tests. Both tests
gave the same result, and only the leucine test is shown.
The full length dMP1 protein was fused with the B42
activation domain (B42AD). The NH2-terminal half of
Corto was fused with the LexA DNA binding domain.
B42AD and LexA were used as negative controls. B42/
SV40 large T-antigen (B42ADT) and LexA/p53
(LexA53) fusion proteins were used as positive controls.
Immunolocalization on polytene chromosomes
Co-immunostaining of w
1118 polytene chromosomes was
performed as previously described [26] using rabbit
anti-ERK (1:20) (C-16; Santa-Cruz Biotechnology), gui-
nea-pig anti-dMP1 (1:20) [ 3 ]a n dr a b b i ta n t i - C o r t o
(1:20) [26] as primary antibodies. Secondary antibodies
(Alexa Fluor
® 594 goat anti-rabbit IgG and Alexa
Fluor
® 488 goat anti-guinea-pig IgG, Molecular Probes)
were used at a 1:1000 dilution.
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